Study Evaluating the Pharmacokinetics of Tigecycline in Human Bone

NCT00376324 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Tigecycline

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer